ストックスクリーナーアプリを入手
15.38
7.93%
1.13
アフターアワーズ：
15.31
-0.07
-0.46%
前日終値:
$14.25
開ける：
$15.23
24時間の取引高:
982.13K
Relative Volume:
0.58
時価総額：
$842.45M
収益：
$15.84M
当期純損益:
$-308.48M
株価収益率:
-2.3735
EPS:
-6.48
ネットキャッシュフロー:
$-153.08M
1週間 パフォーマンス:
+6.66%
1か月 パフォーマンス:
+10.25%
6か月 パフォーマンス:
-2.84%
1年 パフォーマンス:
+91.41%
1日の値動き範囲:
$15.20
$15.49
1週間の範囲:
$13.61
$15.84
52週間の値動き範囲:
$4.45
$19.18
Uniqure N V Stock (QURE) Company Profile
QURE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
15.38 | 780.17M | 15.84M | -308.48M | -153.08M | -6.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-01 | 再開されました | Chardan Capital Markets | Buy |
| 2024-12-10 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-02-29 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-03-17 | アップグレード | UBS | Neutral → Buy |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-21 | 開始されました | UBS | Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-01 | アップグレード | Mizuho | Neutral → Buy |
| 2021-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-24 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-11-09 | 開始されました | Jefferies | Buy |
| 2020-11-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-08-25 | 開始されました | Raymond James | Strong Buy |
| 2020-07-31 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | ダウングレード | Mizuho | Buy → Neutral |
| 2020-06-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | 開始されました | Cowen | Outperform |
| 2019-12-03 | 開始されました | Goldman | Buy |
| 2019-11-05 | 開始されました | Credit Suisse | Outperform |
| 2019-10-11 | 開始されました | Stifel | Buy |
| 2019-09-25 | 開始されました | Bernstein | Outperform |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-07-30 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-07-08 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2019-03-29 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Uniqure N V (QURE) 最新ニュース
uniQure N.V. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
What drives uniQure N.V. stock priceExceptional trading performance - Autocar Professional
Is uniQure N.V. a good long term investmentHigh-velocity gains - jammulinksnews.com
uniQure N.V. to Report Second Quarter 2025 Financial Results and Host Conference Call on July 29, 2025 - Nasdaq
uniQure to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Gene Therapy Leader uniQure Schedules Q2 2025 Earnings: Key Details for Investors - Stock Titan
What analysts say about uniQure N.V. stockHigh-yield market plays - Autocar Professional
Why uniQure N.V. stock attracts strong analyst attentionReal Chart Play - Newser
What makes uniQure N.V. stock price move sharplyHigh Reward Swing Trades - Newser
(QURE) Trading Advice - news.stocktradersdaily.com
Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
uniQure N.V. (NASDAQ:QURE) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
(QURE) Technical Data - news.stocktradersdaily.com
uniQure stock rating reiterated at Buy by Stifel ahead of key data - Investing.com
Is uniQure NV overvalued or undervalued? - MarketsMojo
uniQure N.V. director Balachandran Madhavan sells $30,518 in shares - Investing.com
Lake Street: AMT-130 Could Be Game-Changer For ClearPoint - Insider Monkey
11 Best Genomics Stocks to Buy According to Hedge Funds - Insider Monkey
uniQure N.V. chief legal officer Potts sells $70k in shares By Investing.com - Investing.com South Africa
uniQure: Price And Value Have Caught Up (NASDAQ:QURE) - Seeking Alpha
Assenagon Asset Management S.A. Acquires 261,323 Shares of uniQure (NASDAQ:QURE) - Defense World
uniQure shareholders approve executive compensation, board reappointments - Investing.com India
uniQure shareholders approve executive compensation, board reappointments By Investing.com - Investing.com South Africa
uniQure (QURE) Appoints Kylie O'Keefe to Advance Global Strategy - GuruFocus
uniQure appoints Kylie O’Keefe as Chief Customer and Strategy Officer By Investing.com - Investing.com South Africa
uniQure appoints Kylie O’Keefe as Chief Customer and Strategy Officer - Investing.com India
uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer - GlobeNewswire
uniQure Prepares for Historic Huntington's Disease Treatment Launch with Key Executive Hire - Stock Titan
Learn to Evaluate (QURE) using the Charts - news.stocktradersdaily.com
uniQure (QURE) Positioned for Growth Amid Regulatory Changes - GuruFocus
RFK Jr. looks to fast track rare disease drug approvals (updated) - Seeking Alpha
Bank of America Corp DE Has $1.22 Million Stock Holdings in uniQure (NASDAQ:QURE) - Defense World
Stock Traders Buy Large Volume of uniQure Call Options (NASDAQ:QURE) - Defense World
stifel reiterates buy rating on uniQure stock after CEO meeting By Investing.com - Investing.com UK
uniQure (NASDAQ:QURE) Short Interest Update - Defense World
H.C. Wainwright reaffirms Buy rating on uniQure stock after FDA meeting By Investing.com - Investing.com South Africa
Uniqure N V (QURE) 財務データ
収益
当期純利益
現金流量
EPS
4.91%
0.25%
大文字化:
|
ボリューム (24 時間):